» Articles » PMID: 32761149

Applying Lessons Learned From Low-Resource Settings to Prioritize Cancer Care in a Pandemic

Overview
Journal JAMA Oncol
Specialty Oncology
Date 2020 Aug 8
PMID 32761149
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: The coronavirus disease 2019 (COVID-19) pandemic has forced oncology clinicians and administrators in the United States to set priorities for cancer care owing to resource constraints. As oncology practices adapt to a contracted health care system, expertise gained from partnerships in low-resource settings can be used for guidance. This article provides a primer on priority setting in oncology and ethical guidance based on lessons learned from experience with cancer care priority setting in low-resource settings.

Observations: Lessons learned from real-world experiences are myriad. First, in the setting of limited resources, a utilitarian approach to maximizing survival benefit should guide decision-making. Second, conflicting principles will often arise among stakeholders and decision makers. Third, fair decision-making procedures should be established to ensure moral legitimacy and accountability. Fourth, proactive safeguards must be implemented to protect vulnerable individuals, or disparities in cancer treatment and outcomes will only widen further. Fifth, communication with patients and families about priority setting decisions should be intentional and standardized. Sixth, moral distress among clinicians must be addressed to avoid burnout during a time when resilience is critical.

Conclusions And Relevance: Although the need to triage cancer care may be new to those who underwent training and now practice oncology in high-resource settings, it is familiar for those who practice in low- and middle-income countries. Oncologists in the United States facing unprecedented decisions about prioritization can draw on ethical frameworks and lessons learned from real-world cancer care priority setting in resource-constrained environments.

Citing Articles

Impact of the COVID-19 pandemic on breast cancer patient pathways and outcomes in the United Kingdom and the Republic of Ireland - a scoping review.

Lohfeld L, Sharma M, Bennett D, Gavin A, Hawkins S, Irwin G Br J Cancer. 2024; 131(4):619-626.

PMID: 38704477 PMC: 11333579. DOI: 10.1038/s41416-024-02703-w.


Prioritization of Surgery in Cancer Patients During the COVID-19 Pandemic: Lessons From a Failed Balancing Act.

Donckier V, Estache A, Liberale G, Goldman M Ann Surg Open. 2023; 2(4):e108.

PMID: 37637874 PMC: 10455138. DOI: 10.1097/AS9.0000000000000108.


Systematic scoping review on moral distress among physicians.

Quek C, Ong R, Wong R, Chan S, Chok A, Shen G BMJ Open. 2023; 12(9):e064029.

PMID: 36691160 PMC: 9442489. DOI: 10.1136/bmjopen-2022-064029.


Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.

Puricelli Perin D, Elfstrom K, Bulliard J, Buron A, Campbell C, Flugelman A Prev Med. 2021; 151:106642.

PMID: 34217420 PMC: 8241661. DOI: 10.1016/j.ypmed.2021.106642.


Interruption of cancer screening services due to COVID-19 pandemic: lessons from previous disasters.

Puricelli Perin D, Christensen T, Buron A, Haas J, Kamineni A, Pashayan N Prev Med Rep. 2021; 23:101399.

PMID: 34026465 PMC: 8126519. DOI: 10.1016/j.pmedr.2021.101399.